Certainty Matters.
As healthcare providers face unprecedented changes, certainty matters more than ever. At ICC 2023, we demonstrated how our advanced technology can help give clinicians the tools to deliver personalized treatments with best-in-class clinical workflows. How clinical evidence gives patients greater certainty that they’re receiving the best possible treatment. And how that combination of powerful technology and clinical evidence equips healthcare organizations with greater certainty to make confident investments, helping to ensure future success.
Expand Access to Radiation Therapy Treatments to More Patients
Accuray Booth #B10 at Jio World Convention Center, Mumbai
Educational Demonstrations at ICC 2023
Take part in live demonstrations of Accuray Precision® Treatment Planning System for our cutting-edge technologies, the Radixact® and CyberKnife® Systems and learn how to:
BOOST PLANNING EFFICIENCY
Create and adapt precise, customized treatment plans in less time
ENHANCE USER EXPERIENCE
Automate workflows and provide state-of-the-art treatment planning tools.
IMPROVE PATIENT OUTCOMES
Deliver more personalized and more precise treatment plans for more patients.
Join AEx for Exciting Webinars from your Peers!
Community Engagement: Connect. Exchange. Learn.
We are excited to announce our upcoming webinars, which will allow viewers to watch and gain valuable insights into the latest developments in radiation oncology. Our webinars are designed to provide an educational experience that covers a wide range of topics related to the CyberKnife®, Radixact® and TomoTherapy® platforms. Whether you are a seasoned professional or just starting your career, we are confident that you will find our webinars informative, engaging, and highly beneficial. So, register with us for this exciting opportunity to learn from your peers.
Meet the Accuray Team
Interact with Accuray experts and gain insights into our cutting-edge solutions.
Talk to an Expert
Accuray Symposium
Expert Encounters: A Live Debate on the Merits and Controversies of SBRT and ADT in the Management of Prostate Cancer
Join us at our symposium hosted at ASTRO for two invigorating debates that delve into the forefront of prostate cancer therapies. Prepare to engage as we navigate through contrasting perspectives on topics that are reshaping the trajectory of modern prostate cancer treatment with SBRT and ADT. This event promises to be a platform for lively exchange, allowing radiation oncologists, physicists, radiation therapists, and nurses to broaden their perspectives. Share in compelling discussions as Radiation Oncologist thought leaders debate differing viewpoints on contemporary topics that highly impact prostate cancer care.
Introduction & Conclusion
Dr. Seth Blacksburg, SVP, Chief Medical Officer, Accuray
Debate #1 Moderated by Dr. Jon Haas
ADT is a Critical Component in the Management of UPCa in the Modern Era.
Dr. Amar Kishan vs Dr. Mack Roach
Debate #2 Moderated by Seth Blacksburg
Prostate SBRT has emerged as the ablative therapy of choice for the majority of prostate cancer.
Dr. Richard Stock vs Dr. Robert Timmerman
